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ORIGINAL ARTICLE

Anti-proliferative Effect of Ganoderma Lucidum
Polysaccharide and Triterpenoid Fractions
against Cancer Cells
P Vasanth Raj1*, S A Dhanaraj1, Syed Atif Ali2, Tan Hooi Kuan1,
Shivanashini Mathiyalagan1, Sangidaa Raman1
1) Faculty of Pharmacy, AIMST University, Jalan Bedong Semeling, 08100, Bedong, Kedah Darul Aman, Malaysia.
2) Advanced Medical and Dental Institute (AMDI), Universiti Sains Malaysia (USM),
Bertam, 13200 Kepala Batas, Pulau Pinang, Malaysia.

ABSTRACT
Objectives: To evaluate the anti-cancer activity of Ganoderma lucidum polysaccharide (GLPS) and tritrepenoid fraction
(GLTT), against five different cell lines.
Methods: The collected Ganoderma lucidum was authenticated and extracted with water and methanol to obtain GLPS
and GLTT fractions. Cell lines (Vero, MCF-7, HEp-2, HeLa and A-549) were cultured and maintained as per standard
procedure. Anti-proliferative activity of GLPS and GLTT were studied by standard MTT and SRB assays. Long term
survival studies, nuclear staining and microtubule dynamic studies of GLPS and GLTT were investigated using HeLa
cells.
Results: Both GLPS and GLTT showed better results and specificity towards HeLa cells followed by MCF-7, HEp-2,
A-549 and Vero respectively. Concentration of GLPS and GLTT at 100 μg/ml (below the CTC50 value) was selected
for nuclear staining and molecular dynamic studies. Nuclear staining experiments, Cancer cells showed severe damage
with characteristic apoptotic morphological alterations such as condensation of nuclear and cytoplasm, reduction of
cell volume and fragmentation. Further, GLPS, GLTT were tested for microtubule dynamic assay against HeLa cells
specifically inhibited microtubule network.
Conclusion: The current studies demonstrate the strong inhibitory effect of GLPS and GLTT on cancerous cell lines
at low concentrations.
Keywords: Ganoderma lucidum, mushroom, polysaccharide, triterpenoid, anti-cancer activity
INTRODUCTION
In Chinese tradition Ganoderma lucidum is recognized as
one of the important kinds of mushroom to cure every
kind of disease. Many clinical studies in Asia have used G.
lucidum along with other herbal drugs in combination or as
a single agent1, 2. For the development of pharmaceutical
product it is important to isolate the active ingredients from
G. lucidum and to prove its mechanism of action. A total
of 140 different triterpenes have been identified from G.
lucidum3. Major triterpenes isolated from G. lucidum include
ganoderols, lucidones, applanoxidic and ganoderenic acids
and ganoderols4. Many studies have proved that triterpenes
* For Correspondence:
E-mail: vasanth1780@gmail.com; vasanth@aimst.edu.my
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are one of the important fractions for the therapeutic
efficiency of G. lucidum5. Further, G. lucidum and its extracts
have been reported to be safe in animal studies6, 7. On the
other hand, because of its significant cytotoxicity towards
cancer cells, there is a possibility of adverse effect from the
derivatives of triterpenes on long term use8, 9. The latest
research works on Ganoderma were reported in the area of
antioxidant activity, cardio protective and liver based studies.
Xia et al., 2013 have investigated tritrepenoids isolated from
G. resinaceum on H2O2 induced toxicity in HepG2 cells10.
Effect of G. lucidum on isoproterenol induced myocardial
infraction in rat models were investigated by Cherian et al.,
2009 11. Researchers have also reported anti-cancer activity
of triterpene from G. lucidum against cancer cells and their
signaling pathway4, 12, 13.
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Polysaccharides from G. lucidum are another active fraction
with promising anticancer properties. Anti-oxidant activity
of the polysaccharide fraction from G. lucidum was reported
by Deepalakshmi et al14. FAS /caspase signaling pathway
and effect of polysaccharide fraction of G. lucidum on cancer
cells was reported by Liang et al. Mushroom polysaccharides
are also acknowledged for its immunomodulating and
antitumor properties15. However, mushrooms are known to
be sensitive to the climatic conditions. Studies also indicated
that chemical composition of G. lucidum fruit bodies differ
from one region to another. Environmental and cultivation
conditions of mushroom will definitely have an impact on
the biological activity of the active constituents16. It has
been reported that cultivation condition and strains will have
direct impact on the physiological and distinct properties
of G. lucidum16. Little attention has been paid towards the
Malaysian origin mushrooms and the molecular mechanisms
underlying the anti-cancer property. Therefore, we evaluated
the anti-cancer activity of G. lucidum, cultivated in northern
region of Malaysia. We studied the effect of G. lucidum
polysaccharide (GLPS) and tritrepenoid fraction (GLTT)
against five different cell lines.
MATERIAL AND METHODS
Materials
High purity inorganic solvents, F12 Coons medium
and β- tubulin antibody FITC conjugated,
Antibiotic
solution (Streptomycin 100 μg/ml, Pencillin100 U/ml and
Amphotericin B 250 ng/ml), Dulbecco’s Modified Eagles
Medium (DMEM), Ethidium bromide and Crystal violet
were procured from Sigma Aldrich Co., St. Louis, USA 3-(4,
5 dimethyl thiazole-2 yl) - 2, 5-diphenyl tetrazolium bromide
(MTT), SRB Sulphorhodamine B, was obtained from Acros
Organics., New Jersey, USA. New Born Calf Serum (NBCS)
and Fetal Bovine Serum (FBS) was obtained from PAA
Labs, Austria. GLPS and GLTT were dissolved in DMSO
(Dimethyl Sulfoxide) not exceeding the concentration of
0.1% (v/v), and the volume was made up to 10 ml with
appropriate medium. Prepared stock solution of 1 mg/ml
concentration was membrane filtered and stored at -20oC for
further use. Pure sample of Ganoderma lucidum was gifted by
DXN Pharma Sdn Bhd., Malaysia.
Panel of cell lines and medium
MCF-7 Human breast cancer cell line, Vero African green
monkey kidney cells, HEp-2 Caucasian male larynx epithelial
carcinoma cells, A-549 Human small cell lung carcinoma cells,
HeLa Human cervix carcinoma cells were obtained from
Life Technologies, Bio-diagnostics Sdn Bhd, Malaysia. A-549
cells were maintained in F12 Coon’s cell culture medium

containing L-Glutamine and 10% of fetal calf serum. All
other cells were maintained in DMEM supplemented with
10% New born calf serum, Streptomycin (100 μg/ml),
Penicillin (100 IU/ml) and Amphotericin B (5 μg/ml) at 37oc
temperature and 5% humidified atmosphere with Co2.
Preparation of polysaccharide and triterpene extracts
The preparation of polysaccharide extract was performed
according to the modified protocol of Ke Pan et al., 201317.
The G. lucidum was collected, authenticated and supplied by
DXN Pharma Sdn Bhd. Malaysia. The obtained sample was
dried and coarse powdered in mortar. 200 g of the powder
was soaked in half liter distilled water, followed by refluxing
for 3 h and cooling. The sample was further filtered using
Whatman 41 filter followed by 0.45µm membrane filter. The
filtrate was freeze dried to get a final yield of 20 g of G.
lucidum polysaccharide extract (GLPS). Triterpene extract
was prepared from 350 g of coarse powder subjected to
soxhlet extraction using methanol (1 L) for 20 h. The extract
obtained was concentrated, dried under reduced pressure
and controlled temperature to yield a dark semisolid mass
(28 g, 7%) of G. lucidum triterpene extract (GLTT) which was
preserved in chilled conditions for further studies.
Anti-proliferative activity assay
Cells in exponential growing phase were trypsinized
and seeded into maintenance medium. The cells were
distributed in 96 well titre plate (SPL Life sciences, Korea)
at 10000 cells/well and incubated for 24 h during for the
formation of partial monolayer. They were treated with
various concentrations of GLPS and GLTT and the control
wells received only maintenance medium. Titre plates were
incubated at 37oC with 5% CO2 in a humidified incubator for
a time of 72 h. Inverted microscope was used to study the
morphological changes at different time intervals. Cellular
viability was determined by using MTT18and SRB19 assays at
the end of 72 h of incubation.
Long term survival studies
Cultures were prepared in 25 cm2 tissue culture flask (SPL
Life sciences, Korea) by seeding 5x 104 HeLa cells/ml and
incubate for 48 h. Later the medium was decanted and the
cultures were exposed to different concentrations of GLPS
and GLTT, below CTC50 value and incubated at 37oC for
a time of 72 h. Later the cultures were trypsinized and
seeded into 24 well micro titre plates at a concentration of
5000 cells/ml. Throughout the study, the control groups
were maintained in growth medium. The cultures were
incubated and the numbers of colonies greater than 32 cells
were considered to have retained their regenerative capacity.
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Table 1: Cytotoxicity profile of GLPS and GLTT against five different cell lines
CTC50 in Cell Line (μg/ml)
Hep-2
HeLa
A-549
MTT
SRB
MTT
SRB
MTT
SRB
MTT
SRB
MTT
SRB
GLPS 375.38±4.14 357.22±3.05 168.54±1.88 175.32±2.49 176.47±2.49 184.13±2.45 121.65±2.90 134.56±1.21 195.24±3.13 200.48±2.15
GLTT 354.06±2.35 360.34±1.35 176.43±2.71 187.19±3.43 196.00±2.21 198.07±4.06 136.70±3.66 145.37±2.91 200.44±2.46 207.46±2.71
The cells were exposed to various concentrations of GLPS and GLTT. At the end of 72 h cellular viability was determined by using
MTTand SRB. Number of independent experiments =3, 5 replicates, mean±SD
Vero

MCF-7

Crysal violet (1%) in absolute ethanol was used for staining
the colonies20.
Acridine orange staining
Different morphological changes occurred during apoptosis
and visualized using acridine orange21. The cells were seeded
at low density (5 x 104 HeLa cells/wells) on coverslip in 6 well
microtitre plate (SPL Life sciences, Korea) and incubated for
24 h. Test compounds GLPS and GLTT were added to the
cells. Control wells maintained cells without any treatment.
After 24 h of incubation the microtitre plates were washed
with phosphate buffered saline (PBS) twice and then fixed
with ice cold methanol for 10 min followed by acetone for
10 sec. The cells were rinsed with PBS and stained with 0.1
% acridine orange in PBS for 20 min at room temperature.
Lastly, the cells were washed with PBS thrice and analyzed
under fluorescence microscope.
Microtubule dynamic study
Cells were seeded at low density (5 x 104 HeLa cells/wells)
in 6 well microtitre plates with coverslip and incubated for
24 h. Test compounds GLPS and GLTT were added to the
cells. Control wells maintained cells without any treatment.
After 24 h, the microtitre plates were washed with phosphate
buffered saline (PBS) twice followed by ice cold methanol
treatment for 10 min and acetone for 10 S for fixing the cells.
The cells were rehydrated with PBS containing triton X-100
(1%) at 37oC for 30 min, followed by treatment with 100 μl of
FITC conjugated mouse monoclonal anti β-tubulin antibody
(Sigma) for 45 min at 37oC. The cells were washed with PBS
thrice and analyzed under fluorescence microscope22.
Statistical analysis
All Statistics data are represented as mean±SEM of the
mentioned number of testing. One way ANOVA (Graph Pad
Prism 5.00, Instat Software, San Diego, CA, USA) followed
by Tukey’s post hoc test was used for the statistical analysis.
RESULTS
Anti-proliferative activity
Both extracts of G. lucidum GLPS and GLTT showed
selective toxicity towards cancer cell cultures. Its CTC50
34
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values are 375.38 μg/ml and 354.06 μg/ml for Vero normal
cells as compared to 168.54 μg/ml, 176.47 μg/ml, 121.65
μg/ml and 195.24 μg/ml for cancer cell culture MCF7,
MCF-7, HEp-2, HeLa and A-549 respectively for GLPS.
The extract GLTT was also specific towards cancer cells with
CTC50 values of 176.43 μg/ml towards MCF-7, 196 μg/
ml against HEp-2, 136.70 μg/ml against HeLa and 200.44
against A-549. SRB assay results for GLPS and GLTT were
also found to be similar as that of MTT assay (Table 1).
Both GLPS and GLTT showed better results and specificity
towards HeLa cells followed by MCF-7, HEp-2 and A-549
respectively. Thus, further mechanism based studies were
performed only towards HeLa cells.
Long term survival studies
HeLa cells were used for long term survival study. The cells
were able to retain their regenerative capacity at the lowest
concentration selected (Table 2). Numbers of colonies
greater than 32 cells were considered to have retained their
regenerative capacity. Both GLPS and GLTT with lowest
concentration of 20 μg/ml, exhibited more than 42 colonies.
Concentration of GLPS and GLTT at 100 μg/ml (below the
CTC50 value) was selected for nuclear staining and molecular
dynamic studies.
Table 2: Long term survival studies of GLPS and GLTT using HeLa
cell line
Concentration in (μg/ml)
Number of Colonies
100
3±1.04
80
12 ±1.51
60
21 ±1.63
40
31±1.51
20
42±1.50
Control
47±1.09
6±1.03
GLTT
100
80
14 ±1.47
60
24 ±1.21
40
35±2.09
45±2.09
20
Control
47±1.09
Cultures were exposed to different concentration of GLPS and
GLTT, below CTC50 value and incubated at 37oC for a period of
72 h. Colonies containing more than 32 cells were considered
to have retained their regenerative capacity. Number of
independent experiments =6, mean±SD
GLPS
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Acridine orange staining
Modifications of the nuclear structure is one of the important
aspects to study the morphological changes involved in
cell. Nuclear staining with acridine orange was performed
to visualize the nuclear morphology. HeLa cells were used
for this study. Drug and toxicant concentrations were used
based on CTC50. With respect to acridine orange staining,
green colour represents viable cells, yellow and orange
staining represent early and late apoptotic cells respectively
(Figure 1). Control cells retained their proper shape and
exhibited intact nucleus without any evidence of membrane
blebbing and condensation. Further, cytoplasm of the
control cells were intact and without any disintegration. The
cells challenged with GLPS and GLTT showed extensive

Figure 1: Acridine orange staining; A, HeLa cells untreated;
B, HeLa cells Paclitaxel treated (10 µg/ml); C, HeLa cells GLPS
treated (100 µg/ml); D, HeLa cells GLTT treated (100 µg/ml).

DISCUSSION
Cultivation, collection and use of mushrooms such as
G. lucidum, A. auricular and L. edodes for their medicinal
properties has been a normal practice for hundreds of
years in countries such as China, Korea and Japan2. Even
though many mushrooms are considered to be safe, there are
some reasons for the fear of mushroom poisoning caused
because of the mistaken species detection or environmental
and cultivation conditions of mushroom16. It is always
necessary to evaluate the toxicity of the compounds
before developing any pharmaceutical, nutraceutical and
cosmeceutical product1. In our study, we paid more attention
towards selection of Malaysian origin mushrooms based on
environmental and cultivation conditions of mushrooms. It
is evident from our study that G. lucidum total triterpenes
and polysaccharides fractions were safe against normal cells
without any detectable toxicity and also possessed excellent

damage with characteristic apoptotic and morphological
changes of nuclear and cytoplasmic membrane damage
with condensation, cell volume reduction and also nuclear
fragmentation. The results were similar to that of the
standard drug paclitaxel used at 10 μg/ml.
Microtubule dynamic study
GLPS, GLTT tested for microtubule inhibition assay against
HeLa cells specifically inhibited microtubule network. The
microtubule disturbance caused by GLPS, GLTT in cancer
cells was similar to that of the standard drug paclitaxel used
at 10 μg/ml. The disturbance caused may be due to the
damage caused to microtubule networking which ultimately
damage cancer cells (Figure 2).

Figure 2: Microtubule inhibition studies; HeLa cells stained
with fluoroscien isothiocyanate conjugated (FITC) monoclonal
antibodies specific to β-tubulin. A, HeLa cells untreated; B, HeLa
cells Paclitaxel treated (10 µg/ml); C, HeLa cells GLPS treated
(100 µg/ml); D, HeLa cells GLTT treated (100 µg/ml).

in vitro anticancer activity. Less toxic antioxidant compounds
obtained from mushrooms can be safely and easily included
in nutraceuticals and/or pharmaceuticals as therapeutic
agents6, 7. The finding of the current studies confirms the
safety and low toxicity of GLPS and GLTT towards normal
cells. Further, both extracts showed specific toxicity towards
cancer cells. Many natural compounds have reported
apoptosis as the primary mechanism for their anticancer
activity15. In our study, although both the fractions showed
specific toxicity towards cancer cells, GLPS results were
slightly better when compared with to GLTT and thus we
infer GLPS to be more potent towards cancer cells.
Polysaccharides derived from mushrooms are one of
the best known substances for immunomodulating and
antitumor properties17. Various studies have confirmed
that the immunomodulating and antitumor properties
of polysaccharides fractions depend on factors such as
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structure, site of activity, dose and mechanism16. Knowledge
of the mechanism of action of polysaccharides involved in
signaling pathway, cytokine networks and in the regulation
of cancer are important to be considered. Cell growth is
not only a reflection of the progression of the cell cycle but
also aberrantly regulated in the majority of cancers9. Tumor
regression potential of polysaccharides has been indicated
through the cell cycle arrest and apoptosis mechanisms.
There are several checkpoints involved in the regulation
of cell cycle such as cdks, cdk inhibitiors and cyclins23.
Data gained from the current study indicate that the tested
polysaccharides have potent anti-proliferatory activity against
four different cancer cell lines and also induced apoptosis,
confirmed by nuclear staining experiments. In addition, our
results indicate that the tested polysaccharides fraction has
also damaged the microtubular network of the cancer cells
and thus induced cell death.

ACKNOWLEDGEMENTS

The above results suggest that the tested polysaccharides
have the potential to inhibit the survival of cancer cells and
have promising anti-cancer activity. Anti-tumor activity of
polysaccharides has direct relation with its configuration,
chemical compositions and physical properties7. Other
factors responsible for the anti-cancer activity of
polysaccharides are linkage type of polysaccharide and the
presence of b-glucan15, 17.

3.

Anti-tumor activity of b-D-glucan is well established and
reported. Besides, a few researchers have reported the
anti-tumor and immune stimulating properties of endo
polysaccharides. In our study, we have confirmed the antiproliferatory, nuclear staining and microtubule inhibition
properties of polysaccharide fraction. Further studies such
as the correlation between the anti-tumor potential and the
polysaccharide structure need to be carried out.

The GLPS and GLTT extracts from Ganoderma lucidum
demonstrate strong cytotoxic potential against all the
cancerous cells. Clonogenic assay results also confirm the
cytotoxic activity of the extracts. These extracts also damaged
the microtubule network ultimately destructive towards the
cancer cells. The present study demonstrates that GLPS and
GLTT extracts have potential anti-cancer activity against cell
lines at low concentrations. Overall, GLPS showed slightly
better results compared to GLTT. Thus, it’s worth to further
investigate the mechanism of action of GLPS fraction for its
anti-cancer activity.
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